Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Deferred Taxes (2021 - 2025)

Historic Deferred Taxes for Nutex Health (NUTX) over the last 6 years, with Q3 2025 value amounting to $27.8 million.

  • Nutex Health's Deferred Taxes rose 455000.0% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 31464.98%. This contributed to the annual value of -$13.1 million for FY2024, which is 13010.77% down from last year.
  • According to the latest figures from Q3 2025, Nutex Health's Deferred Taxes is $27.8 million, which was up 455000.0% from -$2.4 million recorded in Q2 2025.
  • Nutex Health's 5-year Deferred Taxes high stood at $27.8 million for Q3 2025, and its period low was -$11.4 million during Q4 2024.
  • Over the past 5 years, Nutex Health's median Deferred Taxes value was -$947734.5 (recorded in 2021), while the average stood at -$278618.7.
  • Over the last 5 years, Nutex Health's Deferred Taxes had its largest YoY gain of 455000.0% in 2025, and its largest YoY loss of 253157.89% in 2025.
  • Nutex Health's Deferred Taxes (Quarter) stood at -$984810.0 in 2021, then soared by 264.61% to $1.6 million in 2022, then tumbled by 324.46% to -$3.6 million in 2023, then plummeted by 213.02% to -$11.4 million in 2024, then surged by 344.14% to $27.8 million in 2025.
  • Its last three reported values are $27.8 million in Q3 2025, -$2.4 million for Q2 2025, and -$2.5 million during Q1 2025.